Effectiveness of sulodexide might be associated with inhibition of complement system in hepatitis B virus-associated membranous nephropathy: An inspiration from a pilot trial
详细信息 查看全文
- 作者：Yang Yanga ; b ; 1 ; Lu Mab ; 1 ; Chao Wangb ; Deyang Kongc ; YaPing Wangd ; Changlin Meia ; kidneyM@163.com" class="auth_mail" title="E-mail the corresponding author ; chlmei1954@126.com" class="auth_mail" title="E-mail the corresponding author
- 关键词：Membranous nephropathy ; Glycosaminoglycan ; Complement ; Hepatitis B virus ; Anti-virus therapy
- 刊名：European Journal of Internal Medicine
- 出版年：2016
- 出版时间：July 2016
- 年：2016
- 卷：32
- 期：Complete
- 页码：96-104
- 全文大小：1935 K
文摘
- •
Confirmed HBV-MN is a kidney disease associated with complement activation.
- •
Sulodexide could inhibit the activation of complement system.
- •
Anti-virus therapy might not obviously affect activation of complement system.
- •
Two agents could both improve the prognosis of the patients with HBV-MN.